LAUSR

SMYD5 acts as a potential biomarker for hepatocellular carcinoma.

Sign Up to like & get
recommendations!
1 Published in 2022 at "Experimental cell research"

DOI: 10.1016/j.yexcr.2022.113076

Abstract: Determining the prognosis of patients remains a challenge due to the phenotypic and molecular diversities of hepatocellular carcinomas (HCC). We aimed to evaluate the role of SMYD5 in HCC. Wilcoxon signed-rank test and logistic regression… read more here.

Keywords: smyd5; hcc; potential biomarker; acts potential ... See more keywords